Episode Details
Back to EpisodesENCORE: A New Revolutionary Technology That Can Predict Cardiovascular Risk With Precision, Part 2
Published 1 year, 11 months ago
Description
Dr. Hoffman continues his conversation with Dr. James Min, an expert on cardiovascular imaging and founder and CEO of Cleerly, a company that has developed an improved scan that can differentiate between dangerous unstable plaque, and more benign lesions.